About the journal
Oncology Reports is a journal published by Elsevier BV in Greece. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier BV
- ISSN
- 1021-335X · 1791-2431
- Country
- Greece
- Access
- Not open access / not declared
- Declared peer-review model
- peer_review
- Official website
- http://www.spandidos-publications.com/or/
Index listings
- MEDLINE · 1998-01-01
- PUBMED · 2011-09-20
- Indexing
- MEDLINE · PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 132 days received→accepted — computed from PubMed (n=100)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
13685
Last recorded publication year
2026
h-index
131
i10-index
9461
From OpenAlex open data (CC0).
Editorial & policy3
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSS
- Open references deposited at Crossref
- 64%
- ORCID iDs in current deposits
- 0%
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9422756
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- RNA modifications and cancer
- RNA modifications and cancer
- Circular RNAs in diseases
- Circular RNAs in diseases
Show all subjects (50)
- Cancer-related Molecular Pathways
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
- Cancer-related gene regulation
- Cell death mechanisms and regulation
- Cell death mechanisms and regulation
- RNA Research and Splicing
- RNA Research and Splicing
- Peptidase Inhibition and Analysis
- Peptidase Inhibition and Analysis
- Cancer, Lipids, and Metabolism
- Cancer, Lipids, and Metabolism
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Cancer Research and Treatments
- Cancer Research and Treatments
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Cancer Mechanisms and Therapy
- Cancer Mechanisms and Therapy
- RNA Interference and Gene Delivery
- RNA Interference and Gene Delivery
- Pancreatic and Hepatic Oncology Research
- Pancreatic and Hepatic Oncology Research
- Genetic factors in colorectal cancer
- Genetic factors in colorectal cancer
- Cell Adhesion Molecules Research
- Cell Adhesion Molecules Research
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Treatments and Studies
- Angiogenesis and VEGF in Cancer
- Angiogenesis and VEGF in Cancer
- Estrogen and related hormone effects
- Estrogen and related hormone effects
- PI3K/AKT/mTOR signaling in cancer
- PI3K/AKT/mTOR signaling in cancer
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ